Neurogene Stock Price Prediction

Intrinsic Valuation Low Real High 12.48 17.58 22.68 Details

Naive Forecast Low Next High 15.36 20.46 25.57 Details

7 Analysts Consensus Low Target High 53.69 59.00 65.49 Details

Earnings Estimates (0) Low Projected EPS High -1.03 -1.03 -1.03 Details

Neurogene After-Hype Price Density Analysis

Neurogene Estimiated After-Hype Price Volatility

Neurogene Stock Price Outlook Analysis

Notes

Neurogene Hype Timeline

Neurogene is now traded for 18.31. The entity has historical hype elasticity of -0.58, and average elasticity to hype of competition of -0.02. Neurogene is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is estimated to be very small, whereas the daily expected return is now at -0.73%. %. The volatility of related hype on Neurogene is about 17689.66%, with the expected price after the next announcement by competition of 18.29. About 91.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.07. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Neurogene recorded a loss per share of 4.1. The entity had not issued any dividends in recent years. The firm had 1:4 split on the 19th of December 2023. Given the investment horizon of 90 days the next estimated press release will be in about 5 days. Check out Neurogene Basic Forecasting Models to cross-verify your projections. For information on how to trade Neurogene Stock refer to our How to Trade Neurogene Stock guide.

Neurogene Related Hype Analysis

Neurogene Additional Predictive Modules

Most predictive techniques to examine Neurogene price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Neurogene using various technical indicators. When you analyze Neurogene charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

The successful prediction of Neurogene stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Neurogene, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Neurogene based on analysis of Neurogene hews, social hype, general headline patterns, and widely used predictive technical indicators.

When running Neurogene's price analysis, check to measure Neurogene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neurogene is operating at the current time. Most of Neurogene's value examination focuses on studying past and present price action to predict the probability of Neurogene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neurogene's price. Additionally, you may evaluate how the addition of Neurogene to your portfolios can decrease your overall portfolio volatility.